Universal Ibogaine's market value is the price at which a share of Universal Ibogaine trades on a public exchange. It measures the collective expectations of Universal Ibogaine investors about its performance. Universal Ibogaine is trading at 0.006 as of the 31st of January 2026. This is a 20.00 percent increase since the beginning of the trading day. The stock's lowest day price was 0.0047. With this module, you can estimate the performance of a buy and hold strategy of Universal Ibogaine and determine expected loss or profit from investing in Universal Ibogaine over a given investment horizon. Check out Universal Ibogaine Correlation, Universal Ibogaine Volatility and Universal Ibogaine Performance module to complement your research on Universal Ibogaine.
Please note, there is a significant difference between Universal Ibogaine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Universal Ibogaine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Universal Ibogaine's market price signifies the transaction level at which participants voluntarily complete trades.
Universal Ibogaine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Universal Ibogaine's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Universal Ibogaine.
0.00
11/02/2025
No Change 0.00
0.0
In 2 months and 31 days
01/31/2026
0.00
If you would invest 0.00 in Universal Ibogaine on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Universal Ibogaine or generate 0.0% return on investment in Universal Ibogaine over 90 days. Universal Ibogaine is related to or competes with Ayala Pharmaceuticals. Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada More
Universal Ibogaine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Universal Ibogaine's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Universal Ibogaine upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Universal Ibogaine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Universal Ibogaine's standard deviation. In reality, there are many statistical measures that can use Universal Ibogaine historical prices to predict the future Universal Ibogaine's volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Universal Ibogaine. Your research has to be compared to or analyzed against Universal Ibogaine's peers to derive any actionable benefits. When done correctly, Universal Ibogaine's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Universal Ibogaine.
Universal Ibogaine January 31, 2026 Technical Indicators
Universal Ibogaine is out of control given 3 months investment horizon. Universal Ibogaine owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.35% are justified by taking the suggested risk. Use Universal Ibogaine Risk Adjusted Performance of 0.0745, semi deviation of 19.07, and Coefficient Of Variation of 1119.39 to evaluate company specific risk that cannot be diversified away. Universal Ibogaine holds a performance score of 8 on a scale of zero to a hundred. The entity has a beta of -3.5, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Universal Ibogaine are expected to decrease by larger amounts. On the other hand, during market turmoil, Universal Ibogaine is expected to outperform it. Use Universal Ibogaine jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on Universal Ibogaine.
Auto-correlation
-0.07
Very weak reverse predictability
Universal Ibogaine has very weak reverse predictability. Overlapping area represents the amount of predictability between Universal Ibogaine time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Universal Ibogaine price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Universal Ibogaine price fluctuation can be explain by its past prices.
Other Information on Investing in Universal Pink Sheet
Universal Ibogaine financial ratios help investors to determine whether Universal Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Universal with respect to the benefits of owning Universal Ibogaine security.